Old Web
English
Sign In
Acemap
>
authorDetail
>
S. Vieira Alves Leon
S. Vieira Alves Leon
Alemtuzumab
Medicine
Internal medicine
Adverse effect
Nephropathy
2
Papers
10
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Alemtuzumab maintains efficacy on clinical and MRI disease activity outcomes, including slowing of brain volume loss, over 9 years in RRMS patients: CARE-MS I follow-up (TOPAZ study)
2019
Multiple Sclerosis Journal
Xavier Montalban
Douglas L. Arnold
Alexey Boyko
G. Comi
H.-P. Hartung
Eva Havrdova
Jihad Inshasi
Pamela A. McCombe
Kunio Nakamura
Celia Oreja-Guevara
Daniel Pelletier
C. Pozzilli
Thomas F. Scott
S. Vieira Alves Leon
Luke Chung
Nadia Daizadeh
S. Afsar
Krzysztof Selmaj
Show All
Source
Cite
Save
Citations (4)
Alemtuzumab maintains efficacy on clinical and MRI disease activity outcomes, including slowing of brain volume loss, over 9 years in RRMS patients: CARE-MS II follow-up (TOPAZ study)
2019
Multiple Sclerosis Journal
Xavier Montalban
D.L. Arnold
A. N. Boyko
G. Comi
H.-P. Hartung
E.K. Havrdova
Jihad Inshasi
Pamela A. McCombe
Kunio Nakamura
Celia Oreja-Guevara
Daniel Pelletier
C. Pozzilli
Thomas F. Scott
S. Vieira Alves Leon
Luke Chung
Nadia Daizadeh
S. Afsar
Krzysztof Selmaj
Show All
Source
Cite
Save
Citations (6)
1